News Detail
HYDERABAD, 27 JUNE 2024: Pharma major Dr Reddy’s Laboratories is acquiring British consumer healthcare player Haleon Plc's entire nicotine replacement therapy (NRT) business, outside of the United States market, for a consideration of GBP 500 million.
As part of ......
View Details
Source : The Times of India
Hyderabad news today
Today news Hyderabad
NRT
Northstar Switzerland
Nicotinell
nicotine replacement therapy
Haleon
Dr Reddy's Laboratories
consumer healthcare
acquire
Related News
- Zydus and Dr. Reddy’s announce licensing agreement for co-marketing of Pertuzumab biosimilar (30-06-2024)
- FDA starts probe into ‘foreign particle’ in saline bottle (30-06-2024)
- 80% of public health facilities are substandard: Govt survey (29-06-2024)
- FSSAI to release tighter regulations for Protein Supplements (29-06-2024)
- Kerala govt issues warning on infectious diseases (29-06-2024)
- Most kids and teens with conjunctivitis prescribed unnecessary antibiotics despite guidelines: Study (29-06-2024)
- Urgent need to strengthen quality management system, documentation & validation processes: DCGI (29-06-2024)
- India to make Ozempic-like drugs for diabetes, obesity under PLI by 2026 (29-06-2024)
- Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India (28-06-2024)
- DCA Telangana seizes spurious 'Vertin Tabs', overpriced 'Itragril-200 Caps' and 3 drugs for misleading claims (28-06-2024)